Re:pair

Company Overview

Snapshot

Founded in July 2019 by Sharon Cohen and Orit Shefi, Re:pair operates with 1–10 employees. The company is currently in the Pre-Funding stage, focusing on developing innovative hydrogel-based platforms for tissue engineering.

Business overview

Re:pair is an Israel-based bioengineering company specializing in the development of remotely activated biostructure scaffolds for tissue-engineered platforms. The company's core technology involves creating off-the-shelf 3D hydrogel-based artificial nerve grafts that mimic natural nerve topography to facilitate peripheral nerve reconstruction. Re:pair operates within the medical devices, tissue repair, and regenerative medicine sectors, targeting neurosurgeons, orthopedists, and plastic surgeons specializing in nerve transplantation surgeries globally.

Company Intelligence Q&A

What is Re:pair's primary focus?

Re:pair is primarily focused on changing the field of tissue-engineered platforms through the development of remotely activated biostructure scaffolds, specifically hydrogel-based solutions for tissue repair and regenerative medicine.

When was Re:pair founded?

Re:pair was founded in July 2019.

Who are the founders of Re:pair?

Re:pair was co-founded by Sharon Cohen and Orit Shefi.

What type of product does Re:pair develop?

Re:pair develops nerve grafts for peripheral nerve reconstruction, utilizing off-the-shelf 3D hydrogel-based artificial grafts designed to mimic natural nerve topography.

Which medical specialists are the target customers for Re:pair's solutions?

Re:pair's solutions are aimed at neurosurgeons, orthopedists, and plastic surgeons who specialize in nerve transplantation surgeries.